Eduardo Asin-Prieto (Eduardo Asín-Prieto)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Emergency Department

Top Venues

Scientific reports

Clinical cancer research : an official journal of the American Association for Cancer Research

The Journal of pharmacology and experimental therapeutics

Inserm U1070

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Inserm U1070 Jan 06 2020

France

Postdoctoral researcher :: Pharmacology of Antimicrobial Agents

Universidad de Navarra Jan 17 2016 - Jan 05 2020

Spain

Post-doctoral position :: Farmacia y Tecnología Farmacéutica

Publications

Idoia Bilbao-Meseguer, Helena Barrasa, Eduardo Asin-Prieto, Ana Alarcia-Lacalle, Alicia Rodríguez-Gascón, Javier Maynar, José Ángel Sánchez-Izquierdo, Goiatz Balziskueta, María Sánchez-Bayton Griffith, Nerea Quilez Trasobares, María Angeles Solinís Aspiazu, Arantxazu Isla
Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function. Pharmaceutics 13 (10) (2021)
Itziar Irurzun-Arana, Eduardo Asin-Prieto, Salvador Martín-Algarra, Iñaki F Trocóniz
Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy. Scientific reports 10 (1) (2020)
Violeta Balbas-Martinez, Eduardo Asin-Prieto, Zinnia P Parra-Guillen, Iñaki F Troconiz
A Quantitative Systems Pharmacology Model for the Key Interleukins Involved in Crohn's Disease. The Journal of pharmacology and experimental therapeutics 372 (3) (2019)
Leire Ruiz-Cerdá, Eduardo Asin-Prieto, Zinnia P Parra-Guillen, Iñaki F Trocóniz
The Long Neglected Player: Modeling Tumor Uptake to Guide Optimal Dosing. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (14) (2018)